[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS)
NewAmsterdam Pharma's Obicetrapib MAA filings are driving positive sentiment, with analysts maintaining 'Buy' ratings. Anticipation builds for potential acquisition news, supported by recent social posts highlighting significant gains and strong market sentiment.
About NewAmsterdam Pharma Company N.V. Ordinary Shares
NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) is a stock in the healthcare sector.
NewAmsterdam Pharma Company N.V. Ordinary Shares uses the ticker $NAMS for trading. Listed in the Stocks category within the Healthcare sectors.
Insights
- NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) sentiment is up XXXXX% from the previous week.
Price: $XXXXX
Price 24-Hour Time-Series Raw Data
NAMS is trading near its 52-week high, supported by positive market sentiment, strong gains, high trading volume, and anticipation of potential acquisition news, as indicated by recent social posts highlighting significant gains and positive market sentiment.
24-Hour: XXXX% 7-Day: XXXX% 30-Day: -XXXX%
1-Year High: $XXXXX on 2025-11-26
1-Year Low: $XXXXX on 2025-04-10
AltRank: XXXXX
AltRank 24-Hour Time-Series Raw Data
NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) is currently AltRank #1,548 based on combined combined social and market metrics
Daily Average: XXXXX
X Week: XXXXX +701
X Month: XXXXX +241
1-Year High: XXXXX on 2025-09-08
1-Year Low: X on 2025-10-12
Galaxy Score: XXXXX
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
X Week: XX -XX
X Month: XX +5
1-Year High: XX on 2025-11-22
1-Year Low: XX on 2025-09-23
Engagements: XXX (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXXXX
X Week: XXXXX -XX%
X Month: XXXXXXX +162%
X Months: XXXXXXX +46%
X Year: XXXXXXXXX +67%
1-Year High: XXXXXX on 2025-11-15
1-Year Low: XXX on 2025-10-29
Engagements by network (24h): X: XXX
Mentions: XX (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XXX -XX%
X Month: XXX -XXXX%
X Months: XXXXX +218%
X Year: XXXXX +122%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-04-28
Mentions by network (24h): X: XXX
Creators: XX (24h)
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) in the last XX hours which is up XX% from XX in the previous XX hours
Daily Average: XX
X Week: XX -XX%
X Month: XXX -XX%
X Months: XXXXX +287%
X Year: XXXXX +215%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-04-28
The most influential creators that mention NewAmsterdam Pharma Company N.V. Ordinary Shares in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @Biotech2k1 | X | XXXXXX | X | XXX |
| @BuyTheUgly | X | XX | X | XXX |
| @BiopharmIQ | X | XXXXXX | X | XXX |
| @BigChodu | X | XXXXX | X | XX |
| @seedytx19 | X | XXXXX | X | XX |
| @SteveDJacobs | X | XXXXX | X | XX |
| @mariostario2019 | X | XX | X | XX |
Sentiment: XX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XXX% +25%
X Month: XXX% no change
X Months: XXX% +12%
X Year: XXX% +4%
1-Year High: XXX% on 2024-12-25
1-Year Low: XX% on 2025-09-14
Most Supportive Themes:
- Bullish Momentum and High-Probability Setups: (40%) Traders are actively seeking and sharing high-probability setups, capitalizing on recent gains and anticipating further upward movement.
- Strong Performance and Positive Market Sentiment: (35%) Posts highlight strong gains, with mentions of significant percentage increases, and overall positive sentiment towards the stock.
- Community Engagement and Watchlist Mentions: (25%) Active engagement within the community, with users sharing watchlists and encouraging others to join groups for insights and opportunities.
Most Critical Themes:
- Network Engagement Breakdown: (5%) The majority of the network engagement is neutral, with a small percentage of negative engagement.
Social Dominance: XXXXXXX%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: XXXXXXX%
X Week: XXXXXX% +0.0004000000000000002%
X Month: XXXXX% +0.0052%
X Months: XXXXX% +0.0019%
X Year: XXXXX% -XXXXX%
1-Year High: XXXXX% on 2024-12-15
1-Year Low: XXXXX% on 2025-09-05
Market Dominance: XXXXXXX%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-11-26
1-Year Low: XXXXXXX% on 2025-12-12
Market Cap: $XXXXXXXXXXXXX
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXX +$6.40%
X Month: $XXXXXXXXXXXXX -$2.80%
1-Year High: $XXXXXXXXXXXXX on 2025-11-26
1-Year Low: $XXXXXXXXXXXXX on 2025-08-28
Top NewAmsterdam Pharma Company N.V. Ordinary Shares Social Posts
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$NAMS NewAmsterdam: Obicetrapib MAA Filings Merit Continued 'Buy' Rating (NASDAQ:NAMS) - Seeking Alpha #stocks #news"
X Link @StockTickerZone 2025-12-10T11:11Z 3980 followers, XXX engagements
"This is HUGE $BMRN $ALEC $ALLO $SUPN $TRVI $BIIB $ARVN $ZURA $NVAX $JAZZ $SBTX $IDYA $INCY $EXEL $CMRX $ALKS $NAMS $ABCL $DAWN $ICPT $IRTC $ACHL $PTGX $KRYS $TGTX $PRVB $ENta $RXRX $AMRN $IRWD $URGN $RPTX $SAGE $ARWR $VACC $TWST $FOLD $MRTX"
X Link @BuyTheUgly 2025-12-09T20:09Z XX followers, XXX engagements
"@simonmaechling There is still hope left for AD patients in CETPI Obicetrapib by $NAMS. One factor that distinguishes it from rest of the failed pursuits is support from Mendelian Randomization studies not to mention a robust XX% decline in p-tau217. Watch out for Ph2B trial to start soon"
X Link @doctorvasan 2025-12-09T19:29Z 1504 followers, XXX engagements
"I nibbled some of $MIRM $ARQT $TVTX $LQDA $IMNM and $NAMS. That should get me back to my 50/50 weight of stocks and cash for $XBI $XXX. Now I can sell more stocks at higher price later as the FOMO goes to $130"
X Link @Biotech2k1 2025-12-09T15:27Z 33.1K followers, 2227 engagements